Literature DB >> 34435485

Immune thrombocytopenia: vaccination does not equal causation.

Allyson Pishko1, Adam Cuker2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 34435485      PMCID： PMC9052899          DOI： 10.3324/haematol.2021.279727

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   11.047


× No keyword cloud information.
  9 in total

Review 1.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

2.  Seasonal variations of incident primary immune thrombocytopenia in adults: An ecological study.

Authors:  Guillaume Moulis; Sophie Guénin; Nicolas Limal; Marc Michel; Philippe Bierling; Bertrand Godeau; Matthieu Mahévas
Journal:  Eur J Intern Med       Date:  2016-10-07       Impact factor: 4.487

3.  Immune thrombocytopenia following vaccination during the COVID-19 pandemic.

Authors:  Philip Young-Ill Choi; Danny Hsu; Huyen Anh Tran; Chee Wee Tan; Anoop Enjeti; Vivien Mun Yee Chen; Beng Hock Chong; Jennifer Curnow; Dominic Pepperell; Robert Bird
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047

4.  Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.

Authors:  W Marieke Schoonen; Gena Kucera; Jenna Coalson; Lin Li; Mark Rutstein; Fionna Mowat; Jon Fryzek; James A Kaye
Journal:  Br J Haematol       Date:  2009-02-24       Impact factor: 6.998

5.  Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).

Authors:  Kerry J Welsh; Jane Baumblatt; Wambui Chege; Ravi Goud; Narayan Nair
Journal:  Vaccine       Date:  2021-04-30       Impact factor: 3.641

6.  Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study.

Authors:  Anton Pottegård; Lars Christian Lund; Øystein Karlstad; Jesper Dahl; Morten Andersen; Jesper Hallas; Øjvind Lidegaard; German Tapia; Hanne Løvdal Gulseth; Paz Lopez-Doriga Ruiz; Sara Viksmoen Watle; Anders Pretzmann Mikkelsen; Lars Pedersen; Henrik Toft Sørensen; Reimar Wernich Thomsen; Anders Hviid
Journal:  BMJ       Date:  2021-05-05

7.  Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.

Authors:  Eun-Ju Lee; Douglas B Cines; Terry Gernsheimer; Craig Kessler; Marc Michel; Michael D Tarantino; John W Semple; Donald M Arnold; Bertrand Godeau; Michele P Lambert; James B Bussel
Journal:  Am J Hematol       Date:  2021-03-09       Impact factor: 13.265

8.  First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.

Authors:  C R Simpson; T Shi; E Vasileiou; S V Katikireddi; S Kerr; E Moore; C McCowan; U Agrawal; S A Shah; L D Ritchie; J Murray; J Pan; D T Bradley; S J Stock; R Wood; A Chuter; J Beggs; H R Stagg; M Joy; R S M Tsang; S de Lusignan; R Hobbs; R A Lyons; F Torabi; S Bedston; M O'Leary; A Akbari; J McMenamin; C Robertson; A Sheikh
Journal:  Nat Med       Date:  2021-06-09       Impact factor: 53.440

9.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.

Authors:  Jamie Lopez Bernal; Nick Andrews; Charlotte Gower; Eileen Gallagher; Ruth Simmons; Simon Thelwall; Julia Stowe; Elise Tessier; Natalie Groves; Gavin Dabrera; Richard Myers; Colin N J Campbell; Gayatri Amirthalingam; Matt Edmunds; Maria Zambon; Kevin E Brown; Susan Hopkins; Meera Chand; Mary Ramsay
Journal:  N Engl J Med       Date:  2021-07-21       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.